Trends and disparities in the US colorectal cancer mortality, 1999-2023: an analysis of the CDC WONDER database.
[BACKGROUND] Colorectal cancer (CRC) remains the second leading cause of cancer-related death in the USA.
APA
Feng Y, Fa X, et al. (2025). Trends and disparities in the US colorectal cancer mortality, 1999-2023: an analysis of the CDC WONDER database.. Frontiers in oncology, 15, 1693240. https://doi.org/10.3389/fonc.2025.1693240
MLA
Feng Y, et al.. "Trends and disparities in the US colorectal cancer mortality, 1999-2023: an analysis of the CDC WONDER database.." Frontiers in oncology, vol. 15, 2025, pp. 1693240.
PMID
41479797
Abstract
[BACKGROUND] Colorectal cancer (CRC) remains the second leading cause of cancer-related death in the USA. This study systematically assessed the spatiotemporal evolution of CRC mortality from 1999 to 2023 and explored sociodemographic and geographic disparities.
[METHODS] Death-certificate data for adults aged ≥ 25 years were extracted from the CDC WONDER database. CRC deaths were identified using ICD-10 codes C18-C20. Age-adjusted mortality rates (AAMR) were calculated with the 2000 US standard population. Stratified analyses were performed by age, sex, race/ethnicity, census region, state, and National Center for Health Statistics urban-rural classification. Joinpoint regression estimated annual percent change (APC) and average annual percent change (AAPC).
[RESULTS] AAMR rose annually by 0.45% in the 25-34-year group and 1.03% in the 35-44-year group but declined significantly among individuals ≥ 55 years (AAPC -1.43% to -3.20%). Adults ≥ 75 years accounted for more than half of CRC deaths. The South registered the highest AAMR (21.13 per 100,000), whereas the Northeast had the lowest (17.31 per 100,000). Non-Hispanic Black individuals experienced the highest AAMR (24.90 per 100,000). Nonmetropolitan counties showed higher AAMR (23.16 per 100,000) than metropolitan counties (18.69 per 100,000).
[CONCLUSION] Despite an overall decline in US CRC mortality, rising risk among young adults and pronounced disparities across regions, racial/ethnic groups, and urban-rural settings persist. Targeted screening and intervention strategies for younger populations, high-burden areas, and vulnerable groups are essential to accelerate equitable reductions in CRC mortality.
[METHODS] Death-certificate data for adults aged ≥ 25 years were extracted from the CDC WONDER database. CRC deaths were identified using ICD-10 codes C18-C20. Age-adjusted mortality rates (AAMR) were calculated with the 2000 US standard population. Stratified analyses were performed by age, sex, race/ethnicity, census region, state, and National Center for Health Statistics urban-rural classification. Joinpoint regression estimated annual percent change (APC) and average annual percent change (AAPC).
[RESULTS] AAMR rose annually by 0.45% in the 25-34-year group and 1.03% in the 35-44-year group but declined significantly among individuals ≥ 55 years (AAPC -1.43% to -3.20%). Adults ≥ 75 years accounted for more than half of CRC deaths. The South registered the highest AAMR (21.13 per 100,000), whereas the Northeast had the lowest (17.31 per 100,000). Non-Hispanic Black individuals experienced the highest AAMR (24.90 per 100,000). Nonmetropolitan counties showed higher AAMR (23.16 per 100,000) than metropolitan counties (18.69 per 100,000).
[CONCLUSION] Despite an overall decline in US CRC mortality, rising risk among young adults and pronounced disparities across regions, racial/ethnic groups, and urban-rural settings persist. Targeted screening and intervention strategies for younger populations, high-burden areas, and vulnerable groups are essential to accelerate equitable reductions in CRC mortality.
같은 제1저자의 인용 많은 논문 (5)
- Efficacy and safety of EGFR monoclonal antibody combined with gemcitabine-based chemotherapy in first-line treatment of locally advanced unresectable or metastatic pancreatic cancer.
- Letter: The Blind Spot of Prostate-Specific Membrane Antigen Positron Emission Tomography Staging? Intraductal Carcinoma of the Prostate Is Overrepresented in Patients With No Uptake Pattern on Prostate-Specific Membrane Antigen Positron Emission Tomography and High-Grade Prostate Cancer: Erratum.
- Preoperative Contrast-enhanced CT Features Associated with Occult Lymph Node Metastasis in Early-Stage Solid Non-Small Cell Lung Cancer.
- Prevalence and risk factors for nausea and vomiting in breast cancer patients undergoing chemotherapy.
- [Research Progress on Glycolytic Reprogramming and Lactylation Crosstalk in Tumors].